Change is in the Air: A Medtech Industry SWOT Analysis (QMED)
Medical device companies are being forced to rethink their business models and strategies, thanks to a changing landscape and the looming 2.3% excise tax currently slated to be levied on devices beginning in January 2013. In light of this dramatically shifting marketplace, Frost & Sullivan has evaluated some of the current strengths, weaknesses, opportunities, and threats to the medical device industry.
Because of the impending impact of this tax, a lot of companies have undergone a great deal of restructuring; we’ve seen spino...
The Orthopedics Industry 
